Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma have?
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma has 275 citations in the OpenAlex counts ScholarIQ stores.
When was Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma published?
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma has 2023 year in the ScholarIQ index.
What is the open-access status of Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma?
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma has green oa status in the ScholarIQ index.
What is the DOI of Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma?
The DOI for Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma is on the source record.
What is the PMID of Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma?
The PMID for Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma is on the source record.
What is the OpenAlex record for Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma?
The OpenAlex for Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma is on the source record.